Vigilant Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $145K | Hold |
277
| – | – | 0.01% | 178 |
|
|
2023
Q1 | $160K | Sell |
277
-159
| -36% | -$91.8K | 0.01% | 159 |
|
|
2022
Q4 | $240K | Sell |
436
-668
| -61% | -$368K | 0.02% | 133 |
|
|
2022
Q3 | $560K | Buy |
1,104
+6
| +0.5% | +$3.04K | 0.05% | 80 |
|
|
2022
Q2 | $597K | Buy |
1,098
+24
| +2% | +$13K | 0.05% | 78 |
|
|
2022
Q1 | $634K | Hold |
1,074
| – | – | 0.05% | 87 |
|
|
2021
Q4 | $717K | Hold |
1,074
| – | – | 0.05% | 83 |
|
|
2021
Q3 | $614K | Buy |
1,074
+145
| +16% | +$82.9K | 0.05% | 77 |
|
|
2021
Q2 | $469K | Buy |
929
+2
| +0.2% | +$1.01K | 0.04% | 90 |
|
|
2021
Q1 | $423K | Sell |
927
-427
| -32% | -$195K | 0.04% | 89 |
|
|
2020
Q4 | $631K | Sell |
1,354
-275
| -17% | -$128K | 0.06% | 66 |
|
|
2020
Q3 | $719K | Buy |
1,629
+275
| +20% | +$121K | 0.08% | 62 |
|
|
2020
Q2 | $491K | Buy |
1,354
+630
| +87% | +$228K | 0.06% | 68 |
|
|
2020
Q1 | $205K | Buy |
724
+445
| +159% | +$126K | 0.03% | 108 |
|
|
2019
Q4 | $91K | Hold |
279
| – | – | 0.01% | 213 |
|
|
2019
Q3 | $81K | Sell |
279
-6
| -2% | -$1.74K | 0.01% | 214 |
|
|
2019
Q2 | $84K | Buy |
285
+6
| +2% | +$1.77K | 0.01% | 197 |
|
|
2019
Q1 | $76K | Sell |
279
-100
| -26% | -$27.2K | 0.01% | 200 |
|
|
2018
Q4 | $85K | Sell |
379
-25
| -6% | -$5.61K | 0.01% | 198 |
|
|
2018
Q3 | $99K | Buy |
404
+34
| +9% | +$8.33K | 0.01% | 203 |
|
|
2018
Q2 | $77K | Sell |
370
-272
| -42% | -$56.6K | 0.01% | 205 |
|
|
2018
Q1 | $133K | Buy |
642
+354
| +123% | +$73.3K | 0.02% | 150 |
|
|
2017
Q4 | $55K | Buy |
288
+43
| +18% | +$8.21K | 0.01% | 212 |
|
|
2017
Q3 | $46K | Hold |
245
| – | – | 0.01% | 183 |
|
|
2017
Q2 | $43K | Hold |
245
| – | – | 0.01% | 172 |
|
|
2017
Q1 | $38K | Hold |
245
| – | – | 0.01% | 180 |
|
|
2016
Q4 | $35K | Sell |
245
-68
| -22% | -$9.71K | 0.01% | 179 |
|
|
2016
Q3 | $50K | Buy |
313
+170
| +119% | +$27.2K | 0.01% | 172 |
|
|
2016
Q2 | $21K | Buy |
+143
| New | +$21K | ﹤0.01% | 225 |
|